Market Update - RPRX - Repros Therapeutics Inc. - UPDATE 1 - TransWorldNews (press release)

July 3, 2009 on 2:37 pm | In Uncategorized | No Comments
Market Update - RPRX - Repros Therapeutics Inc. - UPDATE 1
TransWorldNews (press release)
… with uterine fibroids, or anemia associated with uterine fibroids; in Phase III clinical trials for the chronic treatment of symptoms associated with …

and more »

Related Posts

Repros Therapeutics Provides Update For Proellex Clinical Program - Pharmaceutical Business Review

July 3, 2009 on 1:34 am | In Uncategorized | No Comments
Repros Therapeutics Provides Update For Proellex Clinical Program
Pharmaceutical Business Review
The phase II study demonstrated clinically and statistically significant reductions of the three key pain symptoms, commonly experienced by women with …

and more »

Related Posts

Generic ambien - Tiscali.cz

July 2, 2009 on 7:39 pm | In Uncategorized | No Comments
Generic ambien
Tiscali.cz
According to Vector one these symptoms can be affected. Cheap valium no prescription generic xanax 2, mg soma ferocious sandstorms. …

and more »

Related Posts

Repros Therapeutics Inc.,RPRX - Repros to stop using 50 mg - TransWorldNews (press release)

July 2, 2009 on 10:06 am | In Uncategorized | No Comments
Repros Therapeutics Inc.,RPRX - Repros to stop using 50 mg
TransWorldNews (press release)
… with uterine fibroids, or anemia associated with uterine fibroids; in Phase III clinical trials for the chronic treatment of symptoms associated with …

and more »

Related Posts

FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences - Seeking Alpha

July 2, 2009 on 6:41 am | In Uncategorized | No Comments
FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences
Seeking Alpha
The Phase 2 study that RPRX completed earlier this year demonstrated clinically and statistically significant reductions of the three key pain symptoms …

and more »

Related Posts

Getting around fallopian tube blockage trouble - Pocono Record

July 1, 2009 on 11:34 pm | In Uncategorized | No Comments
Getting around fallopian tube blockage trouble
Pocono Record
Additional internal causes include compression or obstructive problems caused by fibroid(s) — benign uterine tumor — polyp or scar tissue inside the womb …

and more »

Related Posts

Repros Therapeutics Inc. Provides Update for Proellex® Clinical … - PipelineReview.com (press release)

July 1, 2009 on 3:06 pm | In Uncategorized | No Comments
Repros Therapeutics Inc. Provides Update for Proellex® Clinical …
PipelineReview.com (press release)
… Proellex®, is a selective blocker of the progesterone receptor and is being developed for the treatment of symptoms associated with uterine fibroids and …

and more »

Related Posts

FDA Calendar Updates: ACOR, DSCO, HGSI, RPRX, Pharming 0 comments - Seeking Alpha

July 1, 2009 on 2:18 pm | In Uncategorized | No Comments
FDA Calendar Updates: ACOR, DSCO, HGSI, RPRX, Pharming 0 comments
Seeking Alpha
The Phase 2 study that RPRX completed earlier this year demonstrated clinically and statistically significant reductions of the three key pain symptoms …

and more »

Related Posts

FDA Calendar Updates: ACOR, HGSI, RPRX, Pharming 0 comments - Seeking Alpha

July 1, 2009 on 2:18 pm | In Uncategorized | No Comments
FDA Calendar Updates: ACOR, HGSI, RPRX, Pharming 0 comments
Seeking Alpha
The Phase 2 study that RPRX completed earlier this year demonstrated clinically and statistically significant reductions of the three key pain symptoms …

and more »

Related Posts

Repros Therapeutics Inc. Provides Update for Proellex(R) Clinical … - FOXBusiness

July 1, 2009 on 6:48 am | In Uncategorized | No Comments
Repros Therapeutics Inc. Provides Update for Proellex(R) Clinical …
FOXBusiness
… Proellex(R), is a selective blocker of the progesterone receptor and is being developed for the treatment of symptoms associated with uterine fibroids …

and more »

Related Posts

Next Page »

.